CDMO
Three key reasons why Coromandel is betting on NACL
By Arun Jain
—
The Murugappa Group-owned Coromandel International Ltd is betting on its acquisition of NACL Industries Ltd to strengthen its domestic formulations business, Latin American presence ...
Piramal Pharma’s investment portfolio expands the injection volume in complex hospital generic drug business
By Arun Jain
—
2025-01-30 12:01:00 : Piramal Pharma LTD has a strong business in the inhaling anesthesia universal market in the United States and emerging markets Mint ...
